LipoCheck secures funding from prominent investors to expand its digital health platform focused on supporting women with lipedema in Germany and beyond.
Target Information
LipoCheck, a startup based in Leipzig, focuses on addressing the often-overlooked medical condition known as lipedema, a painful fat distribution disorder. The company aims to support and guide women suffering from this condition through a digital platform that includes the LipoCheck and LipoAlly apps. These applications enable users to document their symptoms, access medical knowledge, and benefit from specialized telemedicine services.
Additionally, LipoCheck collaborates closely with health insurance companies and medical professionals to ensure comprehensive care from the initial suspicion of the condition all the way through treatment support. The founding team consists of sisters Anina Langhans and Helena Rapprich, along with their father Dr. Stefan Rapprich, whose clinical experience highlighted the medical need for such a platform.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare technology industry is rapidly evolving, especially in Germany, where there is a strong emphasis on digital health solutions. The country has seen significant investments in health tech startups, drive
Similar Deals
TGFS Technologiegründerfonds Sachsen → Medical Decision Alliance GmbH
2025
TGFS
invested in
LipoCheck
in 2025
in a Seed Stage deal